Protocol CAUSE-03 / CHEETAH

Part of paid clinical trials in Aurora, Colorado.

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Study ID
NCT06136091
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 17 Years
Healthy Volunteers
Accepted

Study Details

This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the year prior to enrollment and cannot demonstrate bronchodilator reversibility at baseline. Phenotypic characteristics will be established at baseline, and the participants will be seen at scheduled visits over 12 months. Each participant will be asked to monitor and self-report cold symptoms and will be asked to complete up to three cold visits

Key Dates

Start date
Apr 23, 2024
Status verified
May 2025
Primary completion
May 1, 2027
Completion
May 1, 2027

Study Design

Enrollment
310 participants (estimated)

Arms

  • Arm: Asthma group
    Participants ages 6 to 17 year old in the asthma group will be seen in clinic quarterly for one year, during periods of disease control when they are not on systemic corticosteroids (SCS)
  • Arm: Non-asthma group
    Participants in the non-asthma group will be seen at two scheduled visits in clinic at 3 and 12 months and will have telephone visits at 6 and 9 months

Primary Outcome Measure

Asthma disease activity measured by the number of exacerbations during the 12-month observation period [ Time Frame: Month 0 to Month 12 ]

Locations (8)

Find similar trials in Aurora, CO

By condition

Related Studies